Finance

Lists
600332:SHA
Guangzhou Baiyunshan Pharmaceutical Holdings Ord Shs A
CNÂ¥19.61
+1.29%
(+0.25) 1D
Oct 30, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600332...
Open
CNÂ¥19.35
High
CNÂ¥19.77
Low
CNÂ¥19.24
Mkt. cap
29.97B
Avg. vol.
6.64M
Volume
9.88M
Dividend
3.82%
Quarterly dividend
CNÂ¥0.19
Ex-dividend date
Sep 10, 2026
P/E ratio
10.82
52-wk high
CNÂ¥27.50
52-wk low
CNÂ¥19.14
EPS
CNÂ¥1.81
Shares outstanding
1.41B
No. of employees
26K
Open
CNÂ¥19.35
High
CNÂ¥19.77
Low
CNÂ¥19.24
Mkt. cap
29.97B
Avg. vol.
6.64M
Volume
9.88M
Dividend
3.82%
Quarterly dividend
CNÂ¥0.19
Ex-dividend date
Sep 10, 2026
P/E ratio
10.82
52-wk high
CNÂ¥27.50
52-wk low
CNÂ¥19.14
EPS
CNÂ¥1.81
Shares outstanding
1.41B
No. of employees
26K
News stories
From web sources and news partners
About Guangzhou Baiyunshan Pharmaceutical Holdings Ord Shs A
CEO-
Employees26.4K
FoundedSep 1, 1997
Headquarters-
SectorHealth care provider
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
16.05B
23.28B
18.81B
19.99B
Cost of goods sold
14.37B
18.55B
16.29B
17.10B
Cost of revenue
14.37B
18.55B
16.29B
17.10B
Research and development expenses
217.91M
158.68M
184.69M
242.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.21B
2.22B
1.83B
1.95B
Operating expense
2.50B
2.55B
2.11B
2.09B
Total operating expenses
16.87B
21.10B
18.40B
19.20B
Operating income
-820.04M
2.18B
409.74M
787.42M
Other non operating income
-100.40M
-1.28M
-15.15M
-426.61M
EBT including unusual items
-494.18M
2.21B
393.99M
581.61M
EBT excluding unusual items
-825.17M
2.21B
377.21M
613.58M
Income tax expense
-156.77M
383.93M
59.00M
174.97M
Effective tax rate
31.72%
17.39%
14.97%
30.08%
Other operating expenses
164.17M
91.90M
62.67M
20.10M
Net income
-326.94M
1.78B
312.16M
395.63M
Net profit margin
-2.04%
7.66%
1.66%
1.98%
Earnings per share
-
-
-
-
Interest and investment income
187.01M
140.88M
97.52M
248.63M
Interest expense
-95.60M
-103.44M
-110.76M
-
Net interest expenses
91.41M
37.44M
-13.24M
248.63M
Depreciation and amortization charges
-
-
-
-
EBITDA
-660.36M
2.34B
583.55M
947.10M
Gain or loss from assets sale
-107.74M
-
-938.61K
938.61K
Upcoming events
AI content may include mistakes. Learn more
Google apps